Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01180660 · ClinicalTrials.gov registry record · NA
IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT01180660 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 51 participants.
The verdict
NCT01180660, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use of intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery. This study has the potential to confirm an opioid sparing strategy for morbid obese patients undergoing laparoscopic gastric bypass surgery. The high incidence of obstructive sleep apnea and the increased risk of postoperative hypoxemia make the development of opioid sparing techniques in this patient population warranted.
Interventions
- DRUG Normal Saline
- DRUG Lidocaine Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01180660
The ClinicalTrials.gov registry entry for NCT01180660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT01180660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01180660 about?
NCT01180660 is a clinical study titled "IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery". Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use of intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after ...
What is the current status of trial NCT01180660?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2010-06. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01180660?
The interventions under investigation include: Normal Saline (DRUG), Lidocaine Infusion (DRUG).
Who is sponsoring clinical trial NCT01180660?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.